Troglitazone

insulin ; Homo sapiens







200 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 11220554 Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. 2000 Jun 2
102 11419922 Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice. 2000 Jan-Feb 7
103 11467307 Safety of drugs commonly used to treat hypertension, dyslipidemia, and type 2 diabetes (the metabolic syndrome): part 1. 2000 Spring 1
104 11480457 Troglitazone improves endothelial dysfunction in patients with insulin resistance. 2000 2
105 9932820 Insulin resistance syndrome: options for treatment. 1999 Jan 1
106 9988406 Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. 1999 Feb 4
107 10051158 Acute troglitazone action in isolated perfused rat liver. 1999 Jan 3
108 10052648 The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders. 1999 Jan-Feb 1
109 10069357 Improving the adverse cardiovascular prognosis of type 2 diabetes. 1999 Feb 2
110 10077340 Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes. 1999 Jan 2
111 10193691 Troglitazone: a review of its use in the management of type 2 diabetes mellitus. 1999 Mar 6
112 10199153 [Insulin-sensitizing agent]. 1999 Mar 3
113 10202252 Troglitazone not only reduced insulin resistance but also improved myotonia in a patient with myotonic dystrophy. 1999 1
114 10231062 Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndrome. 1999 May 4
115 10372240 Effect of troglitazone on body fat distribution in type 2 diabetic patients. 1999 Jun 3
116 10404859 Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus. 1999 Jul 1 1
117 10406828 Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus. 1999 Jul 1
118 10418858 Insulin resistance and thrombosis: a cardiologist's view. 1999 Jul 8 2
119 10431549 Troglitazone. Is it all over? 1999 Jul 1
120 10446394 Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. 1999 Aug 12 4
121 10480188 [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs]. 1999 Aug 1
122 10480527 Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. 1999 Sep 3
123 10484048 Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes. 1999 Sep 1
124 10487503 Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance. 1999 Sep 5
125 10580431 A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. 1999 Dec 6
126 10580614 The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum. 1999 Oct 2
127 10605995 Oral pharmacologic management of type 2 diabetes. 1999 Dec 1
128 10617087 A short synthesis of troglitazone: an antidiabetic drug for treating insulin resistance. 1999 Dec 20 1
129 11220287 Promising new approaches. 1999 May 2
130 12054120 Pharmacological treatments for GH-induced insulin resistance. 1999 Mar 2
131 15251651 Classification of type 2 diabetes by clinical response to metformin-troglitazone combination and C-Peptide criteria. 1999 Nov-Dec 1
132 9454525 Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. 1998 Feb 1 2
133 9516220 Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. 1998 Mar 26 3
134 9519921 The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes. 1998 Mar-Apr 1
135 9533065 Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. 1998 Mar 3
136 9541719 [The thiazolidinones--a new therapeutic agent for type 2 diabetes]. 1998 Feb 4
137 9543098 Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats. 1998 Feb 4
138 9544743 Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. 1998 Jan 3
139 9550122 Temporal profiles and clinical significance of pulsatile insulin secretion. 1998 1
140 9551285 TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. 1998 Apr 1
141 9555358 Focus on insulin resistance in type 2 diabetes: therapeutic implications. 1998 Mar-Apr 1
142 9588096 [The present and future of treatment with oral antidiabetic agents]. 1998 Mar 9 2
143 9588250 Troglitazone: an antidiabetic agent. 1998 May 1 2
144 9589700 Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. 1998 May 2
145 9589814 Insulin resistance: current concepts. 1998 Mar-Apr 1
146 9619341 New approaches to insulin resistance in polycystic ovarian syndrome. 1998 Jun 1
147 9620105 Troglitazone in type II diabetes mellitus. 1998 May-Jun 3
148 9628275 Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. 1998 May 5
149 9647334 Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus. 1998 Jul-Aug 2
150 9667221 Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats. 1998 Jul 4